BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28260429)

  • 1. Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
    Alotaibi F; Kabbani M; Abaalkhail F; Chorley A; Elbeshbeshy H; Al-Hamoudi W; Alabbad S; Boehnert MU; Alsofayan M; Al-Kattan W; Ahmed B; Broering D; Al Sebayel M; Elsiesy H
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):37-41. PubMed ID: 28260429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of [
    Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of metabolic indices of
    Bauschke A; Altendorf-Hofmann A; Brückner L; Drescher R; Freesmeyer M; Settmacher U
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1401-1410. PubMed ID: 35451699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Kang YK; Choi JY; Paeng JC; Kim YI; Kwon HW; Cheon GJ; Suh KS; Kwon CHD; Lee DS; Kang KW
    Eur Radiol; 2019 Nov; 29(11):6009-6017. PubMed ID: 31115626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
    Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
    Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.
    Saberi B; Garonzik-Wang J; Ma M; Ajayi T; Kim A; Luu H; Jakhete N; Pustavoitau A; Anders RA; Georgiades C; Kamel I; Ottmann S; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2020 Aug; 18(4):463-469. PubMed ID: 30084757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography-Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular Cancer.
    Anılır E; Oral A; Turker F; Şahin T; Topçu FS; Yuzer Y; Tokat Y
    Transplant Proc; 2024; 56(1):111-115. PubMed ID: 38212168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using
    Wang ZF; Fan XX; Xu M; Chen MJ; Zhao ZW; Zhou JD; Tu JF; Song JJ; Hu XH; Lu CY; Wu FZ; Zhang DK; Chen L; Liu L; Ying XH; Xu XF; Ji JS
    Tumour Biol; 2017 May; 39(5):1010428317701656. PubMed ID: 28475013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
    Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
    Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
    Bhangui P; Saigal S; Gautam D; Piplani T; Choudhary N; Chaudhary R; Yadav S; Thiagarajan S; Rastogi A; Saraf N; Nundy S; Soin AS
    Liver Transpl; 2021 Feb; 27(2):209-221. PubMed ID: 33253492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Ecker BL; Hoteit MA; Forde KA; Hsu CC; Reddy KR; Furth EE; Siegelman ES; Habibollahi P; Ben-Josef E; Porrett PM; Abt PL; Shaked A; Olthoff KM; Levine MH
    Transplantation; 2018 Apr; 102(4):648-655. PubMed ID: 29319629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of
    Lee SM; Kim HS; Lee S; Lee JW
    World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
    J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation.
    Miao W; Nie P; Yang G; Wang Y; Yan L; Zhao Y; Yu T; Yu M; Wu F; Rao W; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3656-3665. PubMed ID: 33813592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable Brain Metastasis of Hepatocellular Carcinoma by PET-CT After Liver Transplantation: a Case Report.
    Sahin E; Ince V; Sahin TT; Kutlu R; Pasahan R; Yilmaz S
    J Gastrointest Cancer; 2023 Mar; 54(1):270-274. PubMed ID: 34811649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining
    Kornberg A; Witt U; Schernhammer M; Kornberg J; Ceyhan GO; Mueller K; Friess H; Thrum K
    Sci Rep; 2017 Oct; 7(1):14176. PubMed ID: 29074969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Liver Transplantation in Hepatocellular Carcinoma Patients at Siriraj Hospital.
    Kositamongkol P; Sanphasitvong V; Sirivatanauksorn Y; Pongpaibul A; Limsrichamrern S; Mahawithitwong P; Asavakarn S; Tovikkai C; Dumronggittigule W
    Transplant Proc; 2017 Jun; 49(5):1114-1117. PubMed ID: 28583538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation for Hepatocellular Carcinoma: Is There a Tumor Size Limit?
    Daoud A; Teeter L; Ghobrial RM; Graviss EA; Mogawer S; Sholkamy A; El-Shazli M; Gaber AO
    Transplant Proc; 2018 Dec; 50(10):3577-3581. PubMed ID: 30577241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factor of Hepatocellular Carcinoma Recurrence After Liver Transplant: Results From a Single Clinic.
    Bolkvadze R; Kashibadze K; Nakashidze M; Mikeladze L; Beridze D; Beridze S
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):256-262. PubMed ID: 38385408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Pulmonary Nodules in the Pretransplant Evaluation of Liver Transplant Recipients With Hepatocellular Carcinoma.
    Serrano OK; Olgun DC; Goduguchinta V; Bangdiwala A; Odegard MN; Kandaswamy R; Matas AJ; Lake JR; Pruett TL; Chinnakotla S
    Exp Clin Transplant; 2018 Jun; 16(3):314-320. PubMed ID: 29633930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.